Resectable Pancreatic Cancer

• CLINICAL_TRIALS trial_result · 2026-04-16
  Clinical Trial Update: Gemcitabine, Nab-paclitaxel, Durvalumab, and Oleclumab Before Surgery for the Treatment of in Resectable/Borderline Resectable Primary Pancreatic Cancer [Phase 2]

  Phase 2 clinical trial investigating neoadjuvant therapy with gemcitabine, nab-paclitaxel, durvalumab, and oleclumab for resectable or borde…

• CLINICAL_TRIALS research · 2026-03-04
  Clinical Trial Update: EUS-guided CTCs + Multi-omics: Predicting Pancreatic Cancer Recurrence and Metastases

  A planned clinical trial uses endoscopic ultrasound-guided circulating tumor cells combined with multi-omics to predict recurrence and metas…